Available in 57 markets
Xtrackers MSCI USA Health Care UCITS ETF 1D
Xtrackers MSCI USA Health Care UCITS ETF 1D is an exchange-traded fund (ETF) from Xtrackers, traded under the ticker XUHC (ISIN IE00BCHWNW54). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. At its core it is a focused, thematic fund: it concentrates on the health care part of the market, so it lives or dies by that one area rather than the economy as a whole. Underneath, it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't. It passively tracks the MSCI USA Health Care index — mirroring that market instead of paying a manager to pick winners, which keeps costs low, and its largest holdings include ELI LILLY, JOHNSON & JOHNSON and ABBVIE INC. It holds around 61 positions (the ten largest ≈ 60.8%), spreading risk so no single holding decides your outcome. Geographically it leans ~97.3% United States, ~2.2% Ireland and ~0.4% United Kingdom. By industry it concentrates most in ~99.8% Health Care and ~0% Financials. A focused fund like this is typically held as a smaller 'satellite' position around a broader core — a way to lean into one theme, not usually a portfolio's only holding. Income such as dividends is paid out to you as cash (a distributing share class). It holds the underlying investments directly (physical replication); it is domiciled in Ireland and UCITS-regulated, a European standard built to protect everyday investors and trades in USD. On the standard KID risk scale it is rated 5 out of 7, which describes how much its price tends to move rather than whether it is good. It launched in 2017. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from Xtrackers.)
Opens the screener with this filter applied.
About this fund
What you own
The MSCI USA Health Care index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 61 companies across United States in a single purchase.
Dividends
The fund pays dividends out to you as cash, usually a few times a year.
Read more
You get the dividends as cash you can spend or move elsewhere, which some people like for a sense of income. If you would rather it compounded, you buy more units yourself — it will not reinvest on its own the way an accumulating version does. The same fund is often sold in both versions; what it holds underneath is identical.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. €0.20 per €100 a year at 0.20%. Lower is cheaper.
Read more
It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
The bigger picture
What's inside
By sector ?
The 10 biggest holdings make up 60.8% of the fund — the rest is spread across roughly 50 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 16.7% |
| 2 | JOHNSON & JOHNSON | 10.5% |
| 3 | ABBVIE INC | 7.6% |
| 4 | UNITEDHEALTH GROUP INC | 6.4% |
| 5 | MERCK & CO INC | 5.4% |
| 6 | AMGEN INC | 3.3% |
| 7 | THERMO FISHER SCIENTIFIC INC | 3.2% |
| 8 | ABBOTT LABORATORIES | 2.7% |
| 9 | GILEAD SCIENCES INC | 2.6% |
| 10 | INTUITIVE SURGICAL INC | 2.4% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | XUHC | USD | ★ Primary |
| CHF listings | |||
| SIX | XUHC | CHF | |
| EUR listings | |||
| Frankfurt | XUHC | EUR | |
| USD listings | |||
| B2 | XUHC | USD | |
| B2 | XUHCUSD | USD | |
| B3 | XSHCL | USD | |
| B3 | XUHCZ | USD | |
| B3 | XUHCL | USD | |
| B3 | XUHCD | USD | |
| B4 | XUHCGBX | USD | |
| B4 | XUHCUSD | USD | |
| BW | XUHC | USD | |
| E1 | XUHCUSD | USD | |
| E1 | XUHCGBX | USD | |
| E1 | XUHCCHF | USD | |
| E1 | XUHCEUR | USD | |
| EB | XUHCD | USD | |
| EB | XUHCL | USD | |
| EO | XUHCCHF | USD | |
| EP | XUHCUSD | USD | |
| EP | XUHCGBX | USD | |
| EP | XUHCCHF | USD | |
| EP | XUHCEUR | USD | |
| EU | XUHCEUR | USD | |
| EU | XUHCGBX | USD | |
| EU | XUHCUSD | USD | |
| EU | XUHCCHF | USD | |
| EZ | XUHCUSD | USD | |
| EZ | XUHCGBX | USD | |
| EZ | XUHCEUR | USD | |
| EZ | XUHCCHF | USD | |
| GD | XUHC | USD | |
| GF | XUHC | USD | |
| GH | XUHC | USD | |
| GM | XUHC | USD | |
| GS | XUHC | USD | |
| GT | XUHC | USD | |
| GZ | XUHC | USD | |
| I2 | XUHCD | USD | |
| IX | XUHCD | USD | |
| IX | XUHCL | USD | |
| L1 | XUHCD | USD | |
| L1 | XUHCL | USD | |
| L1 | XUHCZ | USD | |
| L3 | XUHCZ | USD | |
| L3 | XUHCL | USD | |
| L3 | XUHCD | USD | |
| L3 | XSHCL | USD | |
| LA | XUHC | USD | |
| LSE | XSHC | USD | |
| LU | XUHC | USD | |
| PO | XUHCZ | USD | |
| PO | XUHCL | USD | |
| PO | XUHCD | USD | |
| PO | XSHCL | USD | |
| PZ | XSHC | USD | |
| PZ | XUHC | USD | |
| QE | XUHCD | USD | |
| QT | XUHC | USD | |
| QX | XUHCD | USD | |
| QX | XUHCL | USD | |
| S1 | XUHCL | USD | |
| S1 | XUHCD | USD | |
| S4 | XUHCD | USD | |
| SE | XUHC | USD | |
| T2 | XUHCEUR | USD | |
| T2 | XUHCUSD | USD | |
| TH | XUHC | USD | |
| X1 | XUHCCHF | USD | |
| X2 | XUHCCHF | USD | |
| X2 | XUHCEUR | USD | |
| X2 | XUHCUSD | USD | |
| X9 | XUHCCHF | USD | |
| X9 | XUHCEUR | USD | |
| X9 | XUHCGBX | USD | |
| X9 | XUHCUSD | USD | |
| XA | XUHCUSD | USD | |
| XA | XUHCGBX | USD | |
| XA | XUHCEUR | USD | |
| XA | XUHCCHF | USD | |
| XB | XUHCEUR | USD | |
| XB | XUHCUSD | USD | |
| XE | XUHCUSD | USD | |
| XE | XUHCGBX | USD | |
| XE | XUHCEUR | USD | |
| XE | XUHCCHF | USD | |
| XF | XUHCUSD | USD | |
| XF | XUHCGBX | USD | |
| XF | XUHCEUR | USD | |
| XF | XUHCCHF | USD | |
| XG | XUHCCHF | USD | |
| XG | XUHCEUR | USD | |
| XG | XUHCGBX | USD | |
| XG | XUHCUSD | USD | |
| XH | XUHCUSD | USD | |
| XH | XUHCGBX | USD | |
| XH | XUHCEUR | USD | |
| XH | XUHCCHF | USD | |
| XJ | XUHCCHF | USD | |
| XJ | XUHCEUR | USD | |
| XJ | XUHCGBX | USD | |
| XJ | XUHCUSD | USD | |
| XL | XUHCUSD | USD | |
| XL | XUHCGBX | USD | |
| XL | XUHCEUR | USD | |
| XL | XUHCCHF | USD | |
| XO | XUHCCHF | USD | |
| XO | XUHCEUR | USD | |
| XO | XUHCGBX | USD | |
| XO | XUHCUSD | USD | |
| XQ | XUHCGBX | USD | |
| XQ | XUHCCHF | USD | |
| XS | XUHCEUR | USD | |
| XS | XUHCGBX | USD | |
| XS | XUHCUSD | USD | |
| XT | XUHCGBX | USD | |
| XT | XUHCUSD | USD | |
| XU | XUHCUSD | USD | |
| XU | XUHCGBX | USD | |
| XU | XUHCEUR | USD | |
| XU | XUHCCHF | USD | |
| XV | XUHCCHF | USD | |
| XV | XUHCEUR | USD | |
| XV | XUHCGBX | USD | |
| XV | XUHCUSD | USD | |
| XW | XUHCUSD | USD | |
| XW | XUHCGBX | USD | |
| XW | XUHCEUR | USD | |
| XW | XUHCCHF | USD | |
| XX | XUHCCHF | USD | |
| XX | XUHCEUR | USD | |
| XX | XUHCGBX | USD | |
| XX | XUHCUSD | USD | |
| XY | XUHCCHF | USD | |
| XZ | XUHCCHF | USD | |
| XZ | XUHCGBX | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-07-17 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 16.7% |
| 2 | JOHNSON & JOHNSON | 10.5% |
| 3 | ABBVIE INC | 7.6% |
| 4 | UNITEDHEALTH GROUP INC | 6.4% |
| 5 | MERCK & CO INC | 5.4% |
| 6 | AMGEN INC | 3.3% |
| 7 | THERMO FISHER SCIENTIFIC INC | 3.2% |
| 8 | ABBOTT LABORATORIES | 2.7% |
| 9 | GILEAD SCIENCES INC | 2.6% |
| 10 | INTUITIVE SURGICAL INC | 2.4% |
| 11 | PFIZER INC | 2.3% |
| 12 | CVS HEALTH CORP | 2.2% |
| 13 | VERTEX PHARMACEUTICALS INC | 2.1% |
| 14 | DANAHER CORP | 2.1% |
| 15 | BRISTOL MYERS SQUIBB | 2.0% |
| 16 | STRYKER CORP | 1.9% |
| 17 | MEDTRONIC PLC | 1.8% |
| 18 | MCKESSON CORP | 1.5% |
| 19 | ELEVANCE HEALTH INC | 1.4% |
| 20 | CIGNA | 1.2% |
| 21 | REGENERON PHARMACEUTICALS INC | 1.1% |
| 22 | BOSTON SCIENTIFIC CORP | 1.1% |
| 23 | HCA HEALTHCARE INC | 1.0% |
| 24 | CARDINAL HEALTH INC | 0.9% |
| 25 | EDWARDS LIFESCIENCES CORP | 0.9% |
| 26 | CENCORA INC | 0.9% |
| 27 | HUMANA INC | 0.8% |
| 28 | BECTON DICKINSON | 0.7% |
| 29 | IDEXX LABORATORIES INC | 0.7% |
| 30 | ALNYLAM PHARMACEUTICALS INC | 0.7% |
| 31 | AGILENT TECHNOLOGIES INC | 0.6% |
| 32 | NATERA INC | 0.6% |
| 33 | WATERS CORP | 0.6% |
| 34 | IQVIA HOLDINGS INC | 0.6% |
| 35 | BIOGEN INC | 0.5% |
| 36 | CENTENE CORP | 0.5% |
| 37 | REVOLUTION MEDICINES INC | 0.5% |
| 38 | ZOETIS INC CLASS A | 0.5% |
| 39 | GE HEALTHCARE TECHNOLOGIES INC | 0.5% |
| 40 | RESMED INC | 0.5% |
| 41 | ILLUMINA INC | 0.5% |
| 42 | DEXCOM INC | 0.5% |
| 43 | VEEVA SYSTEMS INC CLASS A | 0.4% |
| 44 | METTLER TOLEDO INC | 0.4% |
| 45 | WEST PHARMACEUTICAL SERVICES INC | 0.4% |
| 46 | ROYALTY PHARMA PLC CLASS A | 0.4% |
| 47 | QUEST DIAGNOSTICS INC | 0.4% |
| 48 | LABCORP HOLDINGS INC | 0.4% |
| 49 | INSMED INC | 0.4% |
| 50 | UNITED THERAPEUTICS CORP | 0.4% |
| 51 | STERIS | 0.4% |
| 52 | INCYTE CORP | 0.3% |
| 53 | ZIMMER BIOMET HOLDINGS INC | 0.3% |
| 54 | NEUROCRINE BIOSCIENCES INC | 0.3% |
| 55 | MEDLINE INC CLASS A | 0.2% |
| 56 | COOPER INC | 0.2% |
| 57 | INSULET CORP | 0.2% |
| 59 | US DOLLAR | 0.1% |
| 60 | EURO CURRENCY | 0.0% |
| 61 | - | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · United States · CHF ETFs we track.
Advanced risk
Concentration depth
Roughly 61 companies are held, but the largest names carry most of the weight — so it behaves like ~17 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| Xtrackers MSCI USA Health Care UCITS ETF 1DXtrackersYou're viewing | State Street® SPDR® S&P 500® ETF TrustSPDRBroader match | iShares Core S&P 500 UCITS ETFiSharesBroader match | iShares Core S&P 500 UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio S&P 500® ETFSPDRBroader match | iShares Core S&P 500 UCITS ETFiSharesBroader match | Schwab U.S. Dividend Equity ETFSchwabBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksDistributingPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. |
| Index tracked | MSCI USA Health Care | S&P 500 Index | S&P 500 | S&P 500 | S&P 500 Index | S&P 500 | |
| Yearly fee (TER) | 0.00% | 0.09% | 0.10% | 0.10% | 0.02% | 0.07% | 0.06% |
| All-in cost | 0.12% | 0.00% | 0.10% | 0.00% | 0.00% | 0.07% | 0.00% |
| Fund size | €0 | €686.6B | €180.2B | €154.3B | €139.3B | €134B | €88.2B |
| Domicile | Ireland | United States | Ireland | Ireland | United States | Ireland | United States |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +18.3% | +17.4% | +18.3% | +19.4% | +10.2% | ||
| 5-yr return p.a. | +11.5% | +10.4% | +11.5% | +12.8% | +5.5% | ||
| # holdings | 61 | 505 | 511 | 511 | 508 | 511 | 103 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.